Fixed drug eruption with ornidazole having cross-sensitivity to secnidazole but not to other nitro-imidazole compounds: a case report.
Sanmukhani
Jayesh
J
Shah
Viral
V
Baxi
Seema
S
Tripathi
Chandrabhanu
C
D000328:Adult; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D003429:Cross Reactions; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000009:adverse effects / Q000031:analogs & derivatives*; D009593:Nitroimidazoles / Q000009:adverse effects* / Q000737:chemistry; D009950:Ornidazole / Q000008:administration & dosage / Q000009:adverse effects*; D011246:Pregnadienetriols / Q000627:therapeutic use; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D005938:Glucocorticoids; D009593:Nitroimidazoles; D011246:Pregnadienetriols; D008795:Metronidazole; C100065:flucloronide; D009950:Ornidazole; C016724:secnidazole